Loading...
Loading...
Available on 1 platform
Sign in to view source links and access this dataset
A 2026 study by Xu Sun identifies potential therapeutic targets for diffuse large B-cell lymphoma (DLBCL). The analysis uses a two-step training and validation approach involving mendelian randomization of eQTL and pQTL data from a large genome-wide association study, with further verification via colocalization, single-cell analysis, and ex-vivo experiments. The dataset, shared under a CC-BY-4.0 license, includes results identifying 16 genes and 5 plasma proteins as potential targets.
The primary data file is a ZIP archive; contents and internal file formats require inspection after download.